Embolization Particle Market Research Report - Forecast till 2027

Embolization Particle Market Information: By Product Type (Radioembolization & Drug Eluting Beads), Application, (Oncology, Peripheral Vascular Disease, Neurology), Level of Occlusion (Proximal) End User (Hospitals & Clinics) - Forecast till 2027

ID: MRFR/Pharma/3388-CR | November 2017 | Region: Global | 113 pages

Embolization Particle Market Overview


The concept of embolization is a minimally invasive therapy; Embolization Particle is an advanced concept which aims to stop not only bleeding but also means to stop blood flow to a tumor in a scientific order to shrink it or in preparation for complete removal. Embolization Particle, this advanced procedure, few embolized particles or tiny substances are rigorously injected into the vital veins of the clinic’s patients to completely block or eliminate the blood flow to typical cancer cells. The method of embolization is an option for very few patients with already existing tumors that cannot be completely removed by modern surgery. Embolization Particles can be used for treating tumors that are extremely large to be treated with modern ablation (usually larger than 5 cm thickness) processes. Embolization Particles can also be used with ablation. Embolization, without any doubt, does reduce a few of the blood supply to the normal liver tissue which is consisting inside the body, so it may not be a suitable option for a few of the patients whose liver has been busted by diseases such as critical illnesses related to hepatitis or cirrhosis. Embolization Particle is applied in various procedures as a major section of modern interventional radiology.


The embolization particle market is projected to have a healthy expansion during the estimated period. The continuous growing use of this modern embolization technique is an enhanced treatment for various conditions other than cancer diseases such as vascular malformations, and fibrosis which is contributing to the growth of the demand for embolization particles globally. Uninterrupted introduction of technically sound and advanced products with augmented efficiency is also aiding the global market growth.


There has been a constantly increasing demand for modern technology, which expands the major demand for uterine artery embolization particle size; there are plenty of advantages over traditional ones, and rising demand for the embolization particle market, also because lack of proper infrastructure are few of the primary drivers for the embolization particle market share. The large part of Europe is estimated to be the quickest growing area.


COVID 19 Impacts and effects


The COVID 19 has affected 215 countries and the embolization particle market analysis as well. To combat the negative effects, countries lead lockdowns that have adversely affected the embolization particle market. The pandemic leads to several challenges to the sector; it is affected all over the world. Plenty of factors like the risk of uninterrupted production, supply chain, distribution, lack of workforce employees, and much-decreased development activities have primarily affected the ongoing demand and supply. People are not as active as earlier. Major strategic developments are taking place. MNC are investing more in the embolization particle market of the increasing demand from consumers across the globe.  


Market Dynamics




  • Drivers 




According to the data of World Health Organization, around 17.7 million people died every year from cardiovascular diseases in the year 2015, representing approximately 31% of all global deaths. The actual total worldwide volume of various cardiovascular procedures is estimated to increase daily on an average by approximately 3.7% per year to over 18.73 million, which is corresponding to prime surgeries and major transcatheter interventions in the year 2022. But also, a very less number of various interventional neuro cardiologists and different interventional neuroradiology (INR) labs, and rigid regulatory rules may basically trouble the market expansion during the estimated period.


The worldwide embolization particle market is estimated to expand at an average CAGR of 9.64% during the estimated period between 2017-2023.


There are four major regions across the globe that are majorly involved in the embolization particle market size – North America, Europe, Asia Pacific region, and Rest-of-the-World (RoW), depending upon the country-level market sizing. The embolization particle market trends are very comprehensive; you have to understand each and every player of the market. There is no debate that in spite of the occurrences of COVID 19, the latest trends and future opportunities of the market growth will see tremendous spreading opportunities.




  • Opportunities 




The increasing dependence on the market supports several industries around the globe that have doubled. The embolization particle market has come up as quite compelling easy solutions. The embolization particle market has been very wide. There are lots of emerging markets related to embolization particles market all across the world, like India, China, and Brazil, that are projected to grow fast over the estimated years.




  • Restraints




The outbreak of COVID-19 has hard severely knocked out the growing pace of the market because of mandatory closures of consumer markets and general healthcare across the globe; the profit share of the companies has been shrinking. COVID19 has disrupted the entire supply chain. A prolonged lockdown had a negative influence and affected the morale of the big pharma companies.




  • Challenges




The embolization particle market is projected to touch the earnings of an all-time high in 2023, according to an in-depth detailed report by latest Market Research Future (MRFR). Around a CAGR of 9.64% is projected during the assessment period (2023) because of the impressive demand. Lots of factors are boosting the concept. The companies are planning and executing current business operations through innovative techniques. Many factors affect the growth of the embolization particle market, such as market size, trends in global technology, capital investment, etc. 




  • Cumulative Growth Analysis




In case of the embolization particle market, the report claims to have a 9.64% of CAGR by 2023 and a revenue of USD 1,909.76 million by 2023. The demand and craze for it is rising, which has increased market growth. It is also estimated to increase at the most elevated speed over the given figure time frame, which is spreading or expanding across different industry verticals. Additionally, government support and customer interest are helping the market to expand. The development is primarily credited to little and medium undertakings or companies where fewer effort arrangements are significantly required.


Technology Analysis 


The worldwide embolization particle market is projected to witness great substantial growth during the estimated time period because of factors, for example, increasing demand for industrialization, huge investment in oil infrastructure, development in various and large scale industries along with the huge rapid expansion is also acting as another primary growth-inducing factor.


By Division by Structure


The worldwide market is divided on the basis of various product types, modern application, level of occlusion, and end-user. It is subdivided on the basis of the product type. The advanced market is further divided into radioembolization and drug-eluting beads concepts. Again, based on the basis of various applications, the embolization particle market is divided into advanced oncology, urology methods, peripheral vascular disease, neurology issues, and others. Depending on the basis of level of various occlusion, the market is further segmented into modern proximal and distal. Based on the basis of end-user applications, it is further segmented into hospitals & clinics sections, ambulatory services, and others.


On the basis of Geographic Segmentation:




  • North America




  • Europe




  • APAC




  • South America




  • MEA




Division by Application


The primary stakeholders in the market are research organizations, Traders, Importers, and Exporters, Suppliers, Industry end users. The concept is gaining momentum. The enterprises are focusing more intensely on improving product innovation techniques.


Division by Region


The regional analysis of several embolization particle markets is being divided and studied, such as Asia Pacific, North America, European nations, and rest of the world countries. As per Geographical, North America is projected to be the biggest market in terms of profit contribution due to increased adoption of several cloud-based services by way of production systems and by several distribution channels. In addition to this, the countries of Asia Pacific are projected to grow rapidly in market due to increasing investment. Also, there has been a rise in demand in major developing countries. For example, India and China are projected to lead growth in several embolization particle demand in different Asia-Pacific regions.


Regional Analysis


There is no doubt; North America is leading the market due to the presence of the grand global players in this particular region as well as increased technological advancement. 


Competitive Landscape


The market players for the Market industry are:
Guerbet
Terumo
BTG International Ltd
Boston Scientific Corporation
Medtronics
Sirtex
Merit Medical


Regional Analysis




  • North America




    • US




    • Canada




    • Mexico






  • Europe




    • Germany




    • UK




    • France




    • Spain




    • Italy




    • Rest of Europe






  • Asia-Pacific




    • China




    • India




    • Japan




    • Rest of Asia-Pacific






  • Rest of the World




    • The Middle East




    • Africa




    • South America






Recent Developments




  • Market has been primarily divided into several segments, and each segment has profitable trends.




  • The segment is growing day by day; there is a new trend that is responsible for the growth




  • North America and Europe have more market share, but Asia Pacific is growing at a very fast pace.




Report Overview




  • Market overview highlights 




  • Analysis based upon COVID 19




  • Explanation upon the Market Dynamics




  • Value chain analysis 




  • Market segmentation overview




  • The regional analysis




  • Competitive landscape analysis




  • Recent Developments





Report Scope:
Report Attribute/Metric Details
  Market Size   2027: Significant Value
  CAGR   9.64% (2017-2023)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Product Type, Application, Level of Occlusion, End User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Guerbet, Terumo, BTG International Ltd, Boston Scientific Corporation, Medtronics, Sirtex, and Merit Medical.
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers

  • Large number of cardiovascular diseases
  • The emergence of minimally invasive surgeries


  • Frequently Asked Questions (FAQ) :


    Embolization Particle Market can expand at 9.64% CAGR from 2020 to 2027.

    Embolization Particle Market is expected to touch USD 1,909.76 million by 2023.

    Embolization Particle Market is driven by large number of cardiovascular diseases and the emergence of minimally invasive surgeries.

    Embolization Particle Market is challenged by a paucity of interventional radiology labs and interventional radiologists.

    Terumo, Guerbet, BTG International Ltd, Boston Scientific Corporation, Medtronics, Sirtex, and Merit Medical are prominent players of the global embolization particle market.

    1 Report Prologue

    2 Market Introduction

    2.1 Definition 15

    2.2 Scope Of The Study 15

    2.2.1 Research Objective 15

    2.2.2 Assumptions 15

    2.2.3 Limitations 16

    3 Research Methodology

    3.1 Primary Research Methodology 18

    3.2 Secondary Research Methodology 19

    3.3 Market Size Estimation 20

    3.4 Market Share Analysis 22

    3.5 Trade Analysis 22

    3.6 Market Pricing Approach 22

    4 Market Dynamics

    4.1 Introduction 23

    4.2 Driver 24

    4.2.1 Growing Demand Of Embolization Particles For Interventional Radiology And Interventional Cardiovascular Procedure (Impact Weightage- 35%) 24

    4.2.2 Embolization Is Best Minimally Invasive Alternatives Available For The

    Interventional Procedures (Impact Weightage- 30%) 25

    4.2.3 Increasing Prevalence Of Various Types Of Cancer Is One Of The Major Factor Responsible For Market Growth (Impact Weightage- 25%) 26

    4.2.4 Favourable Reimbursement Scenario (Impact Weightage- 10%) 27

    4.3 Restraints 28

    4.3.1 Less Number Of Interventional Neuroradiologists And Interventional

    Neuroradiology (INR) Labs (Impact Weightage- 40%) 28

    4.3.2 Strict Regulatory Rules (Impact Weightage-60% 29

    4.4 Opportunities 30

    4.4.1 Recent Advances In Microsphere Technologies 30

    4.5 Mega Trends 30

    4.6 Macroeconomic Indicators 31

    5 Market Factor Analysis

    5.1 Porter's 5 Forces Analysis 32

    5.1.1 Bargaining Power Of Suppliers 33

    5.1.2 Bargaining Power Of Buyers 33

    5.1.3 Threat Of New Entrants 33

    5.1.4 Threat Of Substitutes 33

    5.1.5 Intensity Of Rivalry 33

    5.2 Value Chain Analysis 34

    5.2.1 R&D 34

    5.2.2 Clinical Test & Legal Issues 35

    5.2.3 Manufacturing 35

    5.2.4 Marketing & Sales 35

    5.3 Purchasing Activities, Strategies And Implications 36

    5.4 Investment Opportunity Analysis 36

    5.5 Pricing Impact Of Embolization Particle (Lipiodol): Effects & Implications 37

    5.6 Reimbursement Issues In Embolization Procedures 38

    6 Global Embolization Particle Market, By Product Type

    6.1 Introduction 40

    6.2 Radioembolization Spheres 41

    6.3 Drug Eluting Beads 42

    7 Global Embolization Particle Market, By Application

    7.1 Introduction 43

    7.2 Oncology 45

    7.3 Urology 46

    7.4 Peripheral Vascular Disease 47

    7.5 Neurology 48

    8 Global Embolization Particle Market, By Level Of Occlusion

    8.1 Introduction 49

    8.1.1 Proximal 50

    8.1.2 Distal 50

    9 Global Embolization Particle Market, By End User

    9.1 Introduction 51

    9.2 Hospitals & Clinics 52

    9.3 Ambulatory Centers 53

    10 Global Embolization Particle Market, By Region

    10.1 Introduction 54

    10.2 Americas 56

    10.2.1 U.S. 59

    10.2.2 Canada 61

    10.2.3 South America 63


    10.3 Europe 66

    10.3.1 Germany 69

    10.3.2 France 71

    10.3.3 UK 73

    10.3.4 Italy 75

    10.3.5 Spain 77

    10.3.6 Rest Of Europe 79

    10.4 Asia Pacific 82

    10.4.1 Japan 85

    10.4.2 China 87

    10.4.3 India 89

    10.4.4 Republic Of Korea 91

    10.4.5 Australia 93

    10.4.6 Rest Of Asia Pacific 95

    10.4.7 Middle East & Africa 97

    11 Competitive Landscape

    11.1 Introduction 100

    11.2 Company Share Analysis 101

    12 Company Profiles

    12.1 Boston Scientific Corporation 102

    12.1.1 Company Overview 102

    12.1.2 Financials 102

    12.1.3 Products 102

    12.1.4 Strategy 102

    12.1.5 Key Developments 102

    12.2 Guerbet 103

    12.2.1 Company Overview 103

    12.2.2 Financials 103

    12.2.3 Products 103

    12.2.4 Strategy 103

    12.2.5 Key Developments 103

    12.3 BTG International Ltd 104

    12.3.1 Company Overview 104

    12.3.2 Financials 104

    12.3.3 Products 104

    12.3.4 Strategy 104

    12.3.5 Key Developments 104

    12.4 Medtronics 105

    12.4.1 Company Overview 105

    12.4.2 Financials 105

    12.4.3 Products 105

    12.4.4 Strategy 105

    12.4.5 Key Developments 105

    12.5 Sirtex 106

    12.5.1 Company Overview 106

    12.5.2 Financials 106

    12.5.3 Products 106

    12.5.4 Strategy 106

    12.5.5 Key Developments 106

    12.6 Terumo 107

    12.6.1 Company Overview 107

    12.6.2 Financials 107

    12.6.3 Products 107

    12.6.4 Strategy 107

    12.6.5 Key Developments 107

    12.7 Merit Medical 108

    12.7.1 Company Overview 108

    12.7.2 Financials 108

    12.7.3 Products 108

    12.7.4 Strategy 108

    12.7.5 Key Developments 108

    13 MRFR Conclusion

    13.1 Key Findings 109

    13.1.1 From CEO’s View Point 109

    13.1.2 Unmet Needs 109

    13.2 Key Companies To Watch 109

    14 Appendix

    14.1 Discussion Blue Print 110

    14.2 References 112

    15 List Of Tables

    TABLE 1 PRIMARY INTERVIEWS 18

    TABLE 2 SAMPLE SIZE DETERMINATION OF END-USERS (HOSPITALS, CLINICS) 19

    TABLE 3 AVERAGE PRICING OF LIPIODOL IN VARIOUS COUNTRIES (USD) 38

    TABLE 4 GLOBAL EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 40

    TABLE 5 GLOBAL EMBOLIZATION PARTICLE MARKET FOR RADIOEMBOLIZATION SPHERES, BY REGION,

    2020-2027 (USD MILLION) 41

    TABLE 6 GLOBAL EMBOLIZATION PARTICLE MARKET FOR DRUG ELUTING BEADS, BY REGION,

    2020-2027 (USD MILLION) 42

    TABLE 7 GLOBAL EMBOLIZATION PARTICLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 43

    TABLE 8 GLOBAL EMBOLIZATION PARTICLE MARKET FOR ONCOLOGY, BY REGION, 2020-2027 (USD MILLION) 45

    TABLE 9 GLOBAL EMBOLIZATION PARTICLE MARKET FOR UROLOGY, BY REGION, 2020-2027 (USD MILLION) 46

    TABLE 10 GLOBAL EMBOLIZATION PARTICLE MARKET FOR PERIPHERAL VASCULAR DISEASE, BY REGION,

    2020-2027 (USD MILLION) 47

    TABLE 11 GLOBAL EMBOLIZATION PARTICLE MARKET FOR NEUROLOGY, BY REGION, 2020-2027 (USD MILLION) 48

    TABLE 12 GLOBAL EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION, 2020-2027 (USD MILLION) 49

    TABLE 13 GLOBAL EMBOLIZATION PARTICLE MARKET FOR PROXIMAL, BY REGION, 2020-2027 (USD MILLION) 50

    TABLE 14 GLOBAL EMBOLIZATION PARTICLE MARKET FOR DISTAL, BY REGION, 2020-2027 (USD MILLION) 50

    TABLE 15 GLOBAL EMBOLIZATION PARTICLE MARKET, BY END USER, 2020-2027 (USD MILLION) 51

    TABLE 16 GLOBAL EMBOLIZATION PARTICLE MARKET FOR HOSPITALS & CLINICS, BY REGION,

    2020-2027 (USD MILLION) 52

    TABLE 17 GLOBAL EMBOLIZATION PARTICLE MARKET FOR AMBULATORY CENTERS, BY REGION,

    2020-2027 (USD MILLION) 53

    TABLE 18 GLOBAL EMBOLIZATION PARTICLE MARKET, BY REGION, 2020-2027 (USD MILLION) 54

    TABLE 19 AMERICAS EMBOLIZATION PARTICLE MARKET, BY COUNTRY, 2020 & 2027 (USD MILLION) 56

    TABLE 20 AMERICA EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 57

    TABLE 21 AMERICA EMBOLIZATION PARTICLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 58

    TABLE 22 AMERICA EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION, 2020-2027 (USD MILLION) 58

    TABLE 23 AMERICA EMBOLIZATION PARTICLE MARKET, BY END USER, 2020-2027 (USD MILLION) 59

    TABLE 24 U.S. EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 59

    TABLE 25 U.S. EMBOLIZATION PARTICLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 60

    TABLE 26 U.S. EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION, 2020-2027 (USD MILLION) 60

    TABLE 27 U.S. EMBOLIZATION PARTICLE MARKET, BY END USER, 2020-2027 (USD MILLION) 61

    TABLE 28 CANADA EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 61

    TABLE 29 CANADA EMBOLIZATION PARTICLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 62

    TABLE 30 CANADA EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION, 2020-2027 (USD MILLION) 62

    TABLE 31 CANADA EMBOLIZATION PARTICLE MARKET, BY END USER, 2020-2027 (USD MILLION) 63

    TABLE 32 SOUTH AMERICA EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 63

    TABLE 33 SOUTH AMERICA EMBOLIZATION PARTICLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 64

    TABLE 34 SOUTH AMERICA EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION,

    2020-2027 (USD MILLION) 64

    TABLE 35 SOUTH AMERICA EMBOLIZATION PARTICLE MARKET, BY END USER, 2020-2027 (USD MILLION) 65

    TABLE 36 EUROPE EMBOLIZATION PARTICLE MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 66

    TABLE 37 EUROPE EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 67

    TABLE 38 EUROPE EMBOLIZATION PARTICLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 68

    TABLE 39 EUROPE EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION, 2020-2027 (USD MILLION) 68

    TABLE 40 EUROPE EMBOLIZATION PARTICLE MARKET, BY END USER, 2020-2027 (USD MILLION) 69

    TABLE 41 GERMANY EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 69

    TABLE 42 GERMANY EMBOLIZATION PARTICLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 70

    TABLE 43 GERMANY EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION, 2020-2027 (USD MILLION) 70

    TABLE 44 GERMANY EMBOLIZATION PARTICLE MARKET, BY END USER, 2020-2027 (USD MILLION) 71

    TABLE 45 FRANCE EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 71

    TABLE 46 FRANCE EMBOLIZATION PARTICLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 72

    TABLE 47 FRANCE EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION, 2020-2027 (USD MILLION) 72

    TABLE 48 FRANCE EMBOLIZATION PARTICLE MARKET, BY END USER, 2020-2027 (USD MILLION) 73

    TABLE 49 UK EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 73

    TABLE 50 UK EMBOLIZATION PARTICLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 74

    TABLE 51 UK EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION, 2020-2027 (USD MILLION) 74

    TABLE 52 UK EMBOLIZATION PARTICLE MARKET, BY END USER, 2020-2027 (USD MILLION) 75

    TABLE 53 ITALY EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 75

    TABLE 54 ITALY EMBOLIZATION PARTICLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 76

    TABLE 55 ITALY EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION, 2020-2027 (USD MILLION) 76

    TABLE 56 ITALY EMBOLIZATION PARTICLE MARKET, BY END USER, 2020-2027 (USD MILLION) 77

    TABLE 57 SPAIN EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 77

    TABLE 58 SPAIN EMBOLIZATION PARTICLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 78

    TABLE 59 SPAIN EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION, 2020-2027 (USD MILLION) 78

    TABLE 60 SPAIN EMBOLIZATION PARTICLE MARKET, BY END USER, 2020-2027 (USD MILLION) 79

    TABLE 61 REST OF EUROPE EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 79

    TABLE 62 REST OF EUROPE EMBOLIZATION PARTICLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 80

    TABLE 63 REST OF EUROPE EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION,

    2020-2027 (USD MILLION) 80

    TABLE 64 REST OF EUROPE EMBOLIZATION PARTICLE MARKET, BY END USER, 2020-2027 (USD MILLION) 81

    TABLE 65 ASIA PACIFIC EMBOLIZATION PARTICLE MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 82

    TABLE 66 ASIA PACIFIC EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 83

    TABLE 67 ASIA PACIFIC EMBOLIZATION PARTICLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 84

    TABLE 68 ASIA PACIFIC EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION, 2020-2027 (USD MILLION) 84

    TABLE 69 ASIA PACIFIC EMBOLIZATION PARTICLE MARKET, BY END USER, 2020-2027 (USD MILLION) 85

    TABLE 70 JAPAN EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 85

    TABLE 71 JAPAN EMBOLIZATION PARTICLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 86

    TABLE 72 JAPAN EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION, 2020-2027 (USD MILLION) 86

    TABLE 73 JAPAN EMBOLIZATION PARTICLE MARKET, BY END USER, 2020-2027 (USD MILLION) 87

    TABLE 74 CHINA EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 87

    TABLE 75 CHINA EMBOLIZATION PARTICLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 88

    TABLE 76 CHINA EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION, 2020-2027 (USD MILLION) 88

    TABLE 77 CHINA EMBOLIZATION PARTICLE MARKET, BY END USER, 2020-2027 (USD MILLION) 89

    TABLE 78 INDIA EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 89

    TABLE 79 INDIA EMBOLIZATION PARTICLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 90

    TABLE 80 INDIA EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION, 2020-2027 (USD MILLION) 90

    TABLE 81 INDIA EMBOLIZATION PARTICLE MARKET, BY END USER, 2020-2027 (USD MILLION) 91

    TABLE 82 REPUBLIC OF KOREA EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 91

    TABLE 83 REPUBLIC OF KOREA EMBOLIZATION PARTICLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 92

    TABLE 84 REPUBLIC OF KOREA EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION,

    2020-2027 (USD MILLION) 92

    TABLE 85 REPUBLIC OF KOREA EMBOLIZATION PARTICLE MARKET, BY END USER, 2020-2027 (USD MILLION) 93

    TABLE 86 AUSTRALIA EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 93

    TABLE 87 AUSTRALIA EMBOLIZATION PARTICLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 94

    TABLE 88 AUSTRALIA EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION, 2020-2027 (USD MILLION) 94

    TABLE 89 AUSTRALIA EMBOLIZATION PARTICLE MARKET, BY END USER, 2020-2027 (USD MILLION) 95

    TABLE 90 REST OF ASIA PACIFIC EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 95

    TABLE 91 REST OF ASIA PACIFIC EMBOLIZATION PARTICLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 96

    TABLE 92 REST OF ASIA PACIFIC EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION,

    2020-2027 (USD MILLION) 96

    TABLE 93 REST OF ASIA PACIFIC EMBOLIZATION PARTICLE MARKET, BY END USER, 2020-2027 (USD MILLION) 97

    TABLE 94 MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE,

    2020-2027 (USD MILLION) 97

    TABLE 95 MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 98

    TABLE 96 MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION,

    2020-2027 (USD MILLION) 98

    TABLE 97 MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET, BY END USER, 2020-2027 (USD MILLION) 99


    16 List Of Figures

    FIGURE 1 GLOBAL EMBOLIZATION PARTICLE MARKET SHARE, BY PRODUCT TYPE, 2020 (%) 12

    FIGURE 2 GLOBAL EMBOLIZATION PARTICLE MARKET SHARE, BY APPLICATIONS, 2020 (%) 13

    FIGURE 3 GLOBAL EMBOLIZATION PARTICLE MARKET, BY REGION, 2020 (%) 14

    FIGURE 4 MARKET STRUCTURE 16

    FIGURE 5 RESEARCH METHODOLOGY 17

    FIGURE 6 FORECAST MODEL 21

    FIGURE 7 PORTERS FIVE FORCES MODEL 32

    FIGURE 8 VALUE CHAIN: TISSUE MICROARRAY 34

    FIGURE 9 GLOBAL EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE, 2020 & 2027 (USD MILLION) 41

    FIGURE 10 GLOBAL EMBOLIZATION PARTICLE MARKET, BY APPLICATION, 2020 & 2027 (USD MILLION) 44

    FIGURE 11 GLOBAL EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION, 2020 & 2027 (USD MILLION) 49

    FIGURE 12 GLOBAL EMBOLIZATION PARTICLE MARKET, BY END USER, 2020 & 2027 (USD MILLION) 51

    FIGURE 13 GLOBAL EMBOLIZATION PARTICLE MARKET, BY REGION, 2020 & 2027 (USD MILLION) 55

    FIGURE 14 AMERICA EMBOLIZATION PARTICLE MARKET, BY COUNTRY, 2020 (%) 57

    FIGURE 15 EUROPE EMBOLIZATION PARTICLE MARKET, BY COUNTRY, 2020 (%) 67

    FIGURE 16 ASIA PACIFIC EMBOLIZATION PARTICLE MARKET, BY COUNTRY, 2020 (%) 83

    FIGURE 17 GLOBAL EMBOLIZATION PARTICLE MARKET: COMPETITIVE LANDSCAPE 100

    FIGURE 18 GLOBAL EMBOLIZATION PARTICLE MARKET: COMPANY SHARE ANALYSIS, 2020 (%) 101